Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJubilee Metals Regulatory News (JLP)

Share Price Information for Jubilee Metals (JLP)

Share Price is delayed by 15 minutes
Get Live Data
2.80    -0.10 (-3.45%)
Bid:
2.70
Ask:
2.90
Spread: 0.20 (7.407%)
Market Cap: £90.25m
JLP Live PriceLast checked at - London Stock Exchange

Intraday Jubilee Metals Share Chart

Investor show and Director Dealing

17 Apr 2015 07:00

RNS Number : 5032K
Jubilee Platinum PLC
17 April 2015
 

Registration number (4459850)

AltX share code: JBL

AIM share code: JLP

ISIN: GB0031852162

 

17 April 2015

Jubilee Platinum PLC

("Jubilee" or "Company")

Investor show and Director Dealing

Jubilee, the AIM-quoted and AltX-listed Mine-to-Metal's specialist, is pleased to announce that Colin Bird, non-executive chairman of the Company, will be presenting on the Company at 14:45 in Whittle Seminar Theatre A at the UK Investor Show, 18 April 2015 at the Queen Elizabeth II Centre, Broad Sanctuary, Westminster, London. The Company will also be available throughout the day at the Company's exhibition stand, number F62.

The Company is also issuing 354,526 new Jubilee ordinary shares ("Shares") at an issue price of 5p per share to Dr Matthews Phosa, who has elected to receive Shares in lieu of 53% of his director's remuneration accrued to him for the period 1 October 2013 to 30 September 2014. The shares are issued under the authority of ordinary resolution number 12 and special resolution number 2 passed at the Company's Annual General Meeting held on 27 November 2013. The issue will bring Dr Phosa's interest in the Company to 986 717 Shares, being 0.14% of the issued capital of the Company.

 

The Shares are issued as fully paid and rank pari passu in all respects with the existing ordinary shares, including the right to receive all dividends and other distributions declared on or after the date on which they are issued.

Application will be made for the Shares to be admitted to trading on AIM ("Admission") and to be listed on the Altx of the JSE Limited, which is expected to take place on or about 23 April 2015.

Total voting rights

Following Admission, the Company's total issued share capital will comprise 712, 360, 507 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

 

Contacts

 

Jubilee Platinum plc

Colin Bird

Tel +44 (0) 20 7584 2155

Leon Coetzer

Tel +27 (0)11 465 1913

Andrew Sarosi

Tel +44 (0) 1752 221937

 

NOMAD

SPARK Advisory Partners Limited

Sean Wyndham-Quin / Mark Brady

+44 (0)113 370 8975

 

JSE Sponsor

Sasfin Capital, a division of Sasfin Bank Limited

Sharon Owens

Tel +27 (0) 11 809 7500

 

Broker

Daniel Stewart and Company PLC

Colin Rowbury - Corporate Broking

Tel: +44 (0) 207 776 6550

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFILSDIRLIE
Date   Source Headline
6th Aug 20207:00 amRNSFurther Copper Tailings Resource Secured in Zambia
13th Jul 20207:00 amRNSSix Month Operations Update
18th Jun 20207:00 amRNSLarge Copper Tailings Resources in Zambia Secured
19th May 202011:30 amRNSRelocation of chrome plant to maximise earnings
7th May 20202:00 pmRNSOperations Update in South Africa and Zambia
17th Apr 20209:15 amRNSUpdate: Operations during lockdown in South Africa
26th Mar 202010:10 amRNSUnaudited interim results
24th Mar 202011:33 amRNSSOUTH AFRICAN 21-DAY LOCKDOWN UPDATE
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:37 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:42 pmRNSPrice Monitoring Extension
20th Mar 20202:05 pmRNSSecond Price Monitoring Extn
20th Mar 20202:00 pmRNSPrice Monitoring Extension
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:37 pmRNSPrice Monitoring Extension
21st Feb 202010:10 amRNSDirector Dealing
28th Jan 20208:15 amRNSSix Monthly Operations Update
6th Dec 201912:45 pmRNSResults of AGM
3rd Dec 20197:00 amRNSDirector Dealing
25th Nov 20192:24 pmRNSTR-1: notification of major holdings
14th Nov 20191:15 pmRNSEquity Placing to Support Targeted Growth
14th Nov 20197:36 amRNSResults for year ended 30 June 2019 & AGM Notice
5th Nov 20198:30 amRNSAcquisition of all chrome rights at Hernic
24th Oct 20193:11 pmRNSAcquisition at Hernic: Transforming Operations
24th Sep 20197:00 amRNSNew Corporate Presentation
17th Sep 20197:00 amRNSKabwe Multi-Metal Processing Project Update
5th Sep 20198:00 amRNSWindsor PGM Project - Full Operational Status
23rd Aug 201910:15 amRNSCompletion of Acquisition in Kabwe & Joint Broker
5th Aug 20199:00 amRNSSix Monthly Operations Update
11th Jul 20197:00 amRNSProjects Update
5th Jun 20191:45 pmRNSProjects Update
9th May 20197:00 amRNSQuarterly Operations Update Q1 2019
3rd May 201912:30 pmRNSTR-1: notification of major holdings
23rd Apr 20197:00 amRNSPrice Monitoring Extension
5th Apr 20192:05 pmRNSSecond Price Monitoring Extn
5th Apr 20192:00 pmRNSPrice Monitoring Extension
4th Apr 20194:41 pmRNSTR-1: notification of major holdings
3rd Apr 20192:26 pmRNSTR-1 NOTIFICATION OF CHANGE IN MAJOR HOLDINGS
2nd Apr 20194:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20191:35 pmRNSVoting Rights and Capital
29th Mar 201910:38 amRNSTR-1: Form for notification of major holdings
28th Mar 20197:00 amRNSUnaudited interim results
21st Mar 201910:58 amRNSFunding secured for Kabwe Project and Acquisition
20th Mar 20194:18 pmRNSGeneral Operations and Projects Update
17th Jan 20198:30 amRNSQuarterly Operations Update Q4 2018
18th Dec 201812:38 pmRNSTR-1: Notification of major holdings
18th Dec 20188:30 amRNSTR-1: notification of major holdings
17th Dec 20187:00 amRNSCommissioning of fine chrome operation commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.